Riboswitches that couple binding of ligands to recruitment of molecular machines offer sensors and control elements for RNA synthetic biology and medical biotechnology. Current approaches to riboswitch design enable significant changes in output activity in the presence vs. absence of input ligands. However, design of these riboswitches has so far required expert intuition and explicit specification of complete target secondary structures, both of which limit the structuretoggling mechanisms that have been explored. We present a fully automated method called RiboLogic for these design tasks and high-throughput experimental tests of 2,875 molecules using RNA-MaP (RNA on a massively parallel array) technology. RiboLogic designs explore an unprecedented diversity of structure-toggling mechanisms validated through experimental tests. These synthetic molecules consistently modulate their affinity to the MS2 bacteriophage coat protein upon binding of flavin mononucleotide, tryptophan, theophylline, and microRNA miR-208a, achieving activation ratios of up to 20 and significantly better performance than control designs. The data enable dissection of features of structure-toggling mechanisms that correlate with higher performance. The diversity of RiboLogic designs and their quantitative experimental characterization provides a rich resource for further improvement of riboswitch models and design methods.
Main textBiological systems rely on precise regulation of cellular processes. In particular, regulatory RNAs, including riboswitches, play major roles in biological circuits, sensing molecules in the cellular milieu and then modulating gene expression and other processes in a wide variety of natural systems. 1 The ability to perform de novo design of arbitrary riboswitches that interact with other biomolecules in their environments would have broad impacts in synthetic biology as well as for RNA diagnostics and therapeutics. Supporting these efforts, there are a rapidly growing number of synthetic and natural RNA 'aptamer' sequences that bind drugs, metabolites, proteins, and other biologically important molecules that might be incorporated into novel riboswitches. Many applications of these riboswitches, including fluorescent biosensors, 2-6 require reversible riboswitches with tight binding to reporters in their ON states, and this criterion necessitates a tradeoff with good activation ratios, defined as the ratio in observed signal in the presence and absence of a trigger molecule. 7Riboswitches are multi-stable RNA molecules, meaning they can form multiple secondary structures. The preferred states can be toggled by small molecule inputs or RNA oligonucleotides that bind aptamers or complementary regions embedded in the RNA ( Figure 1A). So far, the majority of riboswitch design studies involve manual design of the desired states and require detailed specification of the structure-toggling mechanism. 7 For reversible switches, these efforts have required significant trial-and-error; success has been achieved through ...